We are live on ! Find out more
FLNA

Filana Therapeutics

175 hedge funds and large institutions have $439M invested in Filana Therapeutics in 2022 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 44 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 23

60% more call options, than puts

Call options by funds: $276M | Put options by funds: $173M

57% more capital invested

Capital invested by funds: $279M → $439M (+$160M)

29% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 34

17% more funds holding

Funds holding: 149175 (+26)

1.34% more ownership

Funds ownership: 24.89%26.23% (+1.3%)

Holders
175
Holders Change
+26
Holders Change %
+17.45%
% of All Funds
3.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
49
Increased
44
Reduced
34
Closed
23
Calls
$276M
Puts
$173M
Net Calls
+$103M
Net Calls Change
+$106M
Name Holding Trade Value Shares
Change
Change in
Stake
Rafferty Asset Management
76
Rafferty Asset Management
New York
$313K -$30.7K -1,138 -13%
Russell Investments Group
77
Russell Investments Group
United Kingdom
$305K
AWM
78
Apollon Wealth Management
South Carolina
$301K -$52K -1,924 -21%
Ameriprise
79
Ameriprise
Minnesota
$298K +$192K +7,111 New
Envestnet Asset Management
80
Envestnet Asset Management
Illinois
$286K -$77.6K -2,872 -30%
Balyasny Asset Management
81
Balyasny Asset Management
Illinois
$283K +$183K +6,783 New
US Bancorp
82
US Bancorp
Minnesota
$282K +$46.3K +1,715 +34%
HighTower Advisors
83
HighTower Advisors
Illinois
$264K +$171K +6,320 New
Rockefeller Capital Management
84
Rockefeller Capital Management
New York
$262K +$135K +5,000 +392%
Dimensional Fund Advisors
85
Dimensional Fund Advisors
Texas
$260K +$168K +6,227 New
ML
86
McAdam LLC
Pennsylvania
$259K +$167K +6,190 New
AC
87
Aristides Capital
Kentucky
$259K +$167K +6,196 New
AB
88
Amalgamated Bank
New York
$256K +$2.59K +96 +2%
Fifth Third Bancorp
89
Fifth Third Bancorp
Ohio
$247K
DU
90
Delphia (USA)
Ontario, Canada
$235K +$152K +5,618 New
CC
91
Corton Capital
Ontario, Canada
$231K +$149K +5,516 New
GG
92
Golden Green
South Carolina
$228K +$147K +5,445 New
Teacher Retirement System of Texas
93
Teacher Retirement System of Texas
Texas
$227K +$146K +5,420 New
DWM
94
Darwin Wealth Management
Florida
$226K +$170K +6,293 New
Public Employees Retirement Association of Colorado
95
Public Employees Retirement Association of Colorado
Colorado
$224K
SG Americas Securities
96
SG Americas Securities
New York
$215K -$1.25M -46,357 -90%
AQR Capital Management
97
AQR Capital Management
Connecticut
$215K +$139K +5,132 New
PAG
98
Private Advisor Group
New Jersey
$213K +$138K +5,100 New
ASN
99
Advisory Services Network
Georgia
$211K -$30.4K -1,125 -18%
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$211K

FLNA Hedge Fund Activity: Q3 2022 in Review

175 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2022, worth a combined $439M — up 57% from $279M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new FLNA positions and 23 closed out — a net gain of 26 holders — while 44 added to existing stakes and 34 trimmed.

The largest buyer was Invesco, adding an estimated $6.49M. The largest seller was BlackRock, cutting an estimated $4.75M.

  • 175 institutional investors held Filana Therapeutics (FLNA) as of Q3 2022, up from 149 in Q2 2022.
  • Funds reported $439M of Filana Therapeutics stock for Q3 2022, up 57% quarter-over-quarter.
  • 49 funds opened new Filana Therapeutics positions in Q3 2022 and 23 closed out, a net change of +26 holders.
  • The largest Filana Therapeutics buyer in Q3 2022 was Invesco, an estimated $6.49M added.
  • The largest Filana Therapeutics seller in Q3 2022 was BlackRock, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.